Month: July 2013

Prevalence of Dry Eye Disease and its Risk Factors in Visual Display Terminal Users: The Osaka Study – Corrected Proof

by  •  • 0 Comments

Purpose: To investigate tear function and prevalence of dry eye disease (DED) in visual display terminal (VDT) users.Design: Cross-sectional study.Methods: Six hundred and seventy-two young and middle-aged Japanese office workers who used VDT completed questionnaires and underwent dry eye testing. We estimated the prevalence of DED using logistic regression analysis to examine associations between DED and possible risk factors. The ocular surface feature, prevalence of DED, and risk factors were evaluated.Results: Of the 672 workers, 561 (83.5%, mean age: 43.3 ± 9.1 years) completed the questionnaire. The percentage of women with a composite outcome of definite DED or probable DED (Read more...)

Measurement of the Optic Disc Vertical Tilt Angle With Spectral-Domain Optical Coherence Tomography and Influencing Factors – Corrected Proof

by  •  • 0 Comments

Purpose: To report a novel method for measuring the vertical tilt angle of the optic nerve (ON) head and to investigate the associated factors.Design: Cross-sectional diagnostic study.Methods: One hundred and twelve normal, glaucomatous, and glaucoma suspect eyes (99 patients) were enrolled in this study. Subjects underwent a full eye examination, biometry, and spectral-domain optical coherence tomography (SDOCT). The vertical tilt angle was measured on high-resolution cross-sectional SDOCT images passing through the ON head and foveal centers using the inner edges of the Bruch membrane opening as the reference plane. The correlation between the vertical tilt angle with the ovality index (Read more...)

Femtosecond laser-assisted cataract surgery successful in initial pediatric cases

by  •  • 0 Comments

The initial pediatric cases of femtosecond laser-assisted cataract surgery demonstrated that the technology has great potential in young patients, according to one surgeon. “Infants and children are the real winners of the femto technology,” H. Burkhard Dick, MD, OSN Europe Edition Associate Editor, told Ocular Surgery News. “Capsulotomy, the most challenging step of pediatric cataract surgery, becomes safe, much easier and reproducible.”

Read more →

Phase 3 results show InSite drugs unable to fully resolve blepharitis

by  •  • 0 Comments

InSite Vision Inc. has announced top-line clinical results from its DOUBle phase 3 clinical trials for the treatment of moderate-to-severe blepharitis, according to a company press release. The drugs under evaluation, AzaSite Plus (azithromycin 1%, dexamethasone 0.1%) and DexaSite (polycarbophil, edetate disodium, sodium chloride, dexamethasone 0.1%), did not meet the primary endpoint of complete resolution of all clinical signs and symptoms of blepharitis, the release said.They did, however, demonstrate statistically significant improvements in the clinical signs and symptoms at day 15.

Read more →

Frost & Sullivan report: Iran’s healthcare industry on the rise

by  •  • 0 Comments

Iran’s healthcare industry is set for a bright future. The country is ranked 15th among Middle East and Africa countries in terms of long-term investment potential. With a population of 75 million people – more than 50% of which is under the age of 35 – and an enormous amount of wealth coming in from its oil & gas reservoirs, Iran’s GDP is expected to grow at an average of 2.4% over the next 10 years.

Read more →

BLOG: Treat dry eye?

by  •  • 0 Comments

Now that I’ve told you a bit about myself, let’s talk about something infinitely more interesting: You! When it comes to dry eye, the single most important factor to consider is whether or not you actually want to be in the business of treating dry eye.Seriously, it’s not for everyone. Dry eye was almost universally considered the “crabgrass that grows on the lawn of eye care” for decades. Indeed, the emergence of Restasis (cyclosporine ophthalmic emulsion 0.05%, Allergan) is probably the single biggest factor in the development of the modern (Read more...)